<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04919291</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT04919291</nct_id>
  </id_info>
  <brief_title>Direct Comparison of TG and WFO LASIK</brief_title>
  <official_title>Contralateral Comparison of Togoguided LASIK and Wavefront-optimized LASIK</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Nobel Eye Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Nobel Eye Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy to different profiles, direct head-to-head studies had been&#xD;
      conducted. In one previous review study revealed that TG LASIK provided patient with better&#xD;
      uncorrected visual acuity (UCVA) than WFO LASIK and WFG LASIK. In recent previous&#xD;
      contralateral eye studies also showed that TG LASIK induced less postoperative higher-order&#xD;
      aberration than WFO LASIK. However, these studies included only low-to-moderate myopia&#xD;
      patients, for patients with high myopia (spherical equivalent &gt; 6D), the effect of TG LASIK&#xD;
      comparing with WFO LASIK had not been reported before.&#xD;
&#xD;
      The aim of our study is to analyze and compare the visual performance of TG LASIK and WFO&#xD;
      LASIK in high myopia and low-to-moderate myopia patients, , particularly UCVA, corrected&#xD;
      distance visual acuity (CDVA), contrast sensitivity (CS), and wavefront aberration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 26, 2019</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">March 14, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>uncorrected visual acuity and corrected distance visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal wavefront analysis</measure>
    <time_frame>3-months postoperative visit</time_frame>
    <description>horizontal coma aberration (Z 3,1), spherical aberration (Z 4,0), and trefoil aberration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>3-months postoperative visit</time_frame>
    <description>4 spatial frequencies: 3, 6, 12, and 18 cycles per degree (cpd).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of vision questionnaire</measure>
    <time_frame>3-months postoperative visit</time_frame>
    <description>A 11-item questionnaire, item scores range from 0 to 10 and higher item scores in questionnaire indicated more difficulty in achieving specific visual tasks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Keratomileusis, Laser In Situ</condition>
  <condition>Contrast Sensitivity</condition>
  <arm_group>
    <arm_group_label>Topoguided LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topoguided ablation profile on dominant eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wavefront optimized LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wavefront optimized ablation profile on non-dominant eye</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topoguided LASIK</intervention_name>
    <description>Topoguided ablation profile on dominant eye</description>
    <arm_group_label>Topoguided LASIK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wavefront optimized LASIK</intervention_name>
    <description>Wavefront optimized ablation profile on non-dominant eye</description>
    <arm_group_label>Wavefront optimized LASIK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 20 and 50 years old&#xD;
&#xD;
          -  CDVA of both eyes could reach 0.1 logarithm of the minimum angle of resolution&#xD;
             (logMAR)&#xD;
&#xD;
          -  stable refractive errors of myopia and astigmatism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cataract&#xD;
&#xD;
          -  corneal opacities or irregularities&#xD;
&#xD;
          -  dry eye (Schirmer's test I ≤ 5mm)&#xD;
&#xD;
          -  amblyopia&#xD;
&#xD;
          -  coexisting ocular pathologies&#xD;
&#xD;
          -  glaucoma&#xD;
&#xD;
          -  non-dilating pupil&#xD;
&#xD;
          -  history of intraocular surgery, laser therapy, or retinopathy&#xD;
&#xD;
          -  optic nerve or macular diseases&#xD;
&#xD;
          -  estimated postoperative cornea residual stromal thickness less than 250 μm&#xD;
&#xD;
          -  pregnancy or under lactation&#xD;
&#xD;
          -  uncontrolled diabetic mellitus or systemic immune disease&#xD;
&#xD;
          -  refusal or unable to maintain follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Taipei Nobel Eye Clinic</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Sutton G, Lawless M, Hodge C. Laser in situ keratomileusis in 2012: a review. Clin Exp Optom. 2014 Jan;97(1):18-29. doi: 10.1111/cxo.12075. Epub 2013 Jun 21. Review.</citation>
    <PMID>23786377</PMID>
  </reference>
  <reference>
    <citation>Moreno-Barriuso E, Lloves JM, Marcos S, Navarro R, Llorente L, Barbero S. Ocular aberrations before and after myopic corneal refractive surgery: LASIK-induced changes measured with laser ray tracing. Invest Ophthalmol Vis Sci. 2001 May;42(6):1396-403.</citation>
    <PMID>11328757</PMID>
  </reference>
  <reference>
    <citation>Schallhorn SC, Farjo AA, Huang D, Boxer Wachler BS, Trattler WB, Tanzer DJ, Majmudar PA, Sugar A; American Academy of Ophthalmology. Wavefront-guided LASIK for the correction of primary myopia and astigmatism a report by the American Academy of Ophthalmology. Ophthalmology. 2008 Jul;115(7):1249-61. doi: 10.1016/j.ophtha.2008.04.010.</citation>
    <PMID>18598819</PMID>
  </reference>
  <reference>
    <citation>Stonecipher K, Parrish J, Stonecipher M. Comparing wavefront-optimized, wavefront-guided and topography-guided laser vision correction: clinical outcomes using an objective decision tree. Curr Opin Ophthalmol. 2018 Jul;29(4):277-285. doi: 10.1097/ICU.0000000000000495. Review.</citation>
    <PMID>29787391</PMID>
  </reference>
  <reference>
    <citation>Kim J, Choi SH, Lim DH, Yang CM, Yoon GJ, Chung TY. Topography-guided versus wavefront-optimized laser in situ keratomileusis for myopia: Surgical outcomes. J Cataract Refract Surg. 2019 Jul;45(7):959-965. doi: 10.1016/j.jcrs.2019.01.031. Epub 2019 Jun 10.</citation>
    <PMID>31196580</PMID>
  </reference>
  <reference>
    <citation>Kim J, Choi SH, Lim DH, Yoon GJ, Chung TY. Comparison of outcomes after topography-modified refraction versus wavefront-optimized versus manifest topography-guided LASIK. BMC Ophthalmol. 2020 May 14;20(1):192. doi: 10.1186/s12886-020-01459-0. Erratum in: BMC Ophthalmol. 2020 Dec 29;20(1):492.</citation>
    <PMID>32410588</PMID>
  </reference>
  <reference>
    <citation>Ozulken K, Yuksel E, Tekin K, Kiziltoprak H, Aydogan S. Comparison of Wavefront-Optimized Ablation and Topography-Guided Contoura Ablation With LYRA Protocol in LASIK. J Refract Surg. 2019 Apr 1;35(4):222-229. doi: 10.3928/1081597X-20190304-02.</citation>
    <PMID>30984979</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>June 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2021</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Nobel Eye Clinic</investigator_affiliation>
    <investigator_full_name>Chao-Kai Chang</investigator_full_name>
    <investigator_title>Dean, Nobel Eye Institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

